Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lee

Showing results (251-260 of 337) with videos related to

Pageof 34
Sort By:
Advances in Radiation Oncology|October 21, 2020
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C CirrhosisPeter Lee, Yunsheng Ma, Isabel Zacharias, et al.
Materials Science & Engineering. C, Materials for Biological Applications|December 22, 2018
A biocompatible thermoset polymer binder for Direct Ink Writing of porous titanium scaffolds for bone tissue engineeringYunhui Chen, Pingping Han, Luigi-Jules Vandi, et al.
The Journal of Rheumatology|January 17, 2012
Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon diseaseSindhu R Johnson, John T Granton, George A Tomlinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Phase I study of 30-minute infusion of carfilzomib as single agent or in combination with low-dose dexamethasone in patients with relapsed and/or refractory multiple myelomaKyriakos P Papadopoulos, David S Siegel, David H Vesole, et al.
Journal for Immunotherapy of Cancer|March 24, 2021
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancerColt Egelston, Weihua Guo, Susan Yost, et al.
Igie : Innovation, Investigation and Insights|April 13, 2026
Adenoma detection rates during screening colonoscopy performed by interventional gastroenterologists and general gastroenterologistsJordan Burlen, Stacey Culp, Michelle Messer, et al.
The American Journal of Managed Care|December 21, 2017
Evaluation of the Quality Blue Primary Care program on health outcomesQian Shi, Thomas J Yan, Peter Lee, et al.
JTO Clinical and Research Reports|December 9, 2022
Utilization and Outcomes of Radiation in Stage IV Esophageal CancerPeter Lee Zhan, Maureen E Canavan, Theresa Ermer, et al.
Journal of Managed Care Pharmacy : JMCP|April 4, 2012
Implications of Risk Evaluation and Mitigation Strategy (REMS) programs for managed care pharmacy, Gaurang Gandhi, Ashley Chon, et al.
BMJ Open|July 23, 2024
Long-term cost-effectiveness analysis of rugby fans in training-New Zealand: a body weight reduction programme for malesPeter Lee, Elaine Hargreaves, Yannan Jiang, et al.
Pageof 34

Showing results (251-260 of 337) with videos related to

Sort By:
Pageof 34
Advances in Radiation Oncology|October 21, 2020
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C CirrhosisPeter Lee, Yunsheng Ma, Isabel Zacharias, et al.
Materials Science & Engineering. C, Materials for Biological Applications|December 22, 2018
A biocompatible thermoset polymer binder for Direct Ink Writing of porous titanium scaffolds for bone tissue engineeringYunhui Chen, Pingping Han, Luigi-Jules Vandi, et al.
The Journal of Rheumatology|January 17, 2012
Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon diseaseSindhu R Johnson, John T Granton, George A Tomlinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Phase I study of 30-minute infusion of carfilzomib as single agent or in combination with low-dose dexamethasone in patients with relapsed and/or refractory multiple myelomaKyriakos P Papadopoulos, David S Siegel, David H Vesole, et al.
Journal for Immunotherapy of Cancer|March 24, 2021
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancerColt Egelston, Weihua Guo, Susan Yost, et al.
Igie : Innovation, Investigation and Insights|April 13, 2026
Adenoma detection rates during screening colonoscopy performed by interventional gastroenterologists and general gastroenterologistsJordan Burlen, Stacey Culp, Michelle Messer, et al.
The American Journal of Managed Care|December 21, 2017
Evaluation of the Quality Blue Primary Care program on health outcomesQian Shi, Thomas J Yan, Peter Lee, et al.
JTO Clinical and Research Reports|December 9, 2022
Utilization and Outcomes of Radiation in Stage IV Esophageal CancerPeter Lee Zhan, Maureen E Canavan, Theresa Ermer, et al.
Journal of Managed Care Pharmacy : JMCP|April 4, 2012
Implications of Risk Evaluation and Mitigation Strategy (REMS) programs for managed care pharmacy, Gaurang Gandhi, Ashley Chon, et al.
BMJ Open|July 23, 2024
Long-term cost-effectiveness analysis of rugby fans in training-New Zealand: a body weight reduction programme for malesPeter Lee, Elaine Hargreaves, Yannan Jiang, et al.
Pageof 34